Standout Papers

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk pa... 2008 2026 2014 2020 696
  1. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial (2008)
    Salim Yusuf, K. K. Teo et al. The Lancet

Immediate Impact

1 by Nobel laureates 2 from Science/Nature 75 standout
Sub-graph 1 of 17

Citing Papers

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis
2020 Standout
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
3 intermediate papers

Works of K. K. Teo being referenced

Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial
2008 Standout

Author Peers

Author Last Decade Papers Cites
K. K. Teo 1221 103 173 302 22 1.6k
Elaine Chiquette 506 83 188 319 35 1.8k
S Oparil 778 57 158 305 14 1.3k
Nora M. Cosgrove 1001 87 337 233 56 1.6k
Vijaya M Musini 681 47 196 244 46 1.4k
Philip Joseph 758 58 281 185 48 1.9k
CJ Bulpitt 971 36 213 246 49 1.6k
Balraj S Heran 1696 421 169 250 23 2.2k
Marcelo C. Shibata 1679 78 162 248 20 2.0k
Bruce M. Psaty 911 24 189 324 18 1.7k
Karin Manhem 752 57 155 334 77 1.5k

All Works

Loading papers...

Rankless by CCL
2026